AABB participates in a variety of meetings and collaborations:
Meeting Summary between AABB and the European Commission (DG SANTE B4)
AABB and the ISCT have formed a Joint Working Group, as a collaborative effort to identify and facilitate project(s) of common interest to both organizations.
AABB/ISCT Working Group Update - 4/4/19
The Cellular Therapy FDA Liaison Meeting brings together representatives from the cellular therapy community with FDA and other relevant federal government agencies to exchange information on topics of mutual interest.
FDA Liaison Meeting - 11/19/24
FDA Liaison Meeting - 12/08/23
FDA Liaison Meeting - 11/15/21
FDA Liaison Meeting - 11/21/19
FDA Liaison Meeting - 3/05/19
FDA Liaison Meeting - 1/30/18
FDA Liaison Meeting - 10/19/16
2018 Center for Biologics Evaluation and Research Science Symposium
Days 1 and 2 videos are available
Cell Notes: What FDA’s Regulatory Flexibility Means for the Future of Cell and Gene Therapy
January 27, 2026
FDA Announces More Flexible Approach to CGT Regulation
January 13, 2026
REGULATORY UPDATE: FDA Releases 2026 CBER Guidance Agenda
January 12, 2026